MedTrace Logo

Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis II

NCT03797937 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2022-05-11

No results posted yet for this study

Summary

The goal of this longitudinal study is to (1) explore the association between the gut microbiota and inflammatory disease activity in early onset multiple sclerosis, (2) investigate whether/how gut microbial composition vary when patients experience a relapse, and (3) to assess whether the gut microbiota shows increased similarities between affected pairs of first-degree relatives within the same family when compared with discordant pairs of first-degree relatives.

Conditions

Interventions

OTHER

Magnetic resonance imaging (MRI)

MRI scanner

Sponsors & Collaborators

  • National MS Center Melsbroek

    lead OTHER

Principal Investigators

  • Marie D'hooghe, M.D. · National MS Center Melsbroek

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2021-11-01
Completion
2022-05-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03797937 on ClinicalTrials.gov